We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Zevalin Post-marketing Surveillance in Japan (ZEVALIN-DUI)

This study is currently recruiting participants.
Verified October 2015 by Spectrum Pharmaceuticals, Inc
Sponsor:
ClinicalTrials.gov Identifier:
NCT01448928
First Posted: October 7, 2011
Last Update Posted: November 2, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Bayer
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)